Please use this identifier to cite or link to this item:
Validation of a Lysis Buffer Containing 4 M Guanidinium Thiocyanate (GITC)/ Triton X-100 for Extraction of SARS-CoV-2 RNA for COVID-19 Testing: Comparison of Formulated Lysis Buffers Containing 4 to 6 M GITC, Roche External Lysis Buffer and Qiagen RTL Lysis Buffer
Scallan Martina F..
Dempsey Catherine.
MacSharry John.
O’Callaghan Isabelle.
O’Connor Paula M..
Horgan Conor P..
Durack Edel.
Cotter Paul D..
Hudson Sarah.
Moynihan Humphrey A..
Lucey Brigid.
Acceso Abierto
AbstractThe COVID-19 pandemic has resulted in increased need for diagnostic testing using reverse transcriptase real-time PCR (RT-PCR). An exponential increase in demand has resulted in a shortage of numerous reagents in particular those associated with the lysis buffer required to extract the viral RNA. Herein, we describe a rapid collective effort by hospital laboratory scientists, academic researchers and the biopharma industry to generate a validated lysis buffer. We have formulated a 4M Guanidinium thiocyanate (GITC)/ Triton X-100 Lysis buffer which provides comparable results with the recommended reagents. This buffer will ease the burden on hospital labs in their heroic efforts to diagnose a large population of patients.
Appears in Collections:Artículos científicos

Upload archives

File SizeFormat 
1102831.pdf469.11 kBAdobe PDFView/Open